{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:50:02Z","timestamp":1791654602567,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.josat.2026.210090","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T15:09:32Z","timestamp":1786806572000},"page":"210090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Varenicline for the management of cannabis use disorder: A systematic review"],"prefix":"10.1016","volume":"191","author":[{"given":"Courtney","family":"Craig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Waldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Daglish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.josat.2026.210090_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/02791072.2017.1370746","article-title":"Feasibility and preliminary effectiveness of varenicline for treating co-occurring cannabis and tobacco use","volume":"50","author":"Adams","year":"2018","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.josat.2026.210090_bb0020","author":"Australian Institute of Health Welfare"},{"issue":"1","key":"10.1016\/j.josat.2026.210090_bb0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-021-00247-4","article-title":"Cannabis use and cannabis use disorder","volume":"7","author":"Connor","year":"2021","journal-title":"Nature Reviews. Disease Primers"},{"key":"10.1016\/j.josat.2026.210090_bb0040","article-title":"Progress toward pharmacotherapies for cannabis-use disorder: An evidence-based review","volume":"41","author":"Copeland","year":"2020","journal-title":"Substance Abuse and Rehabilitation"},{"issue":"12","key":"10.1016\/j.josat.2026.210090_bb0055","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1001\/jamapediatrics.2019.3553","article-title":"Efficacy and safety of varenicline for adolescent smoking cessation: A randomized clinical trial","volume":"173","author":"Gray","year":"2019","journal-title":"JAMA Pediatrics"},{"key":"10.1016\/j.josat.2026.210090_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109672","article-title":"Varenicline and related interventions on smoking cessation: A systematic review and network meta-analysis","volume":"241","author":"Guo","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.josat.2026.210090_bb0065","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/adb.12664","article-title":"Varenicline and nabilone in tobacco and cannabis co-users: Effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse","volume":"24","author":"Herrmann","year":"2018","journal-title":"Addiction Biology"},{"issue":"2","key":"10.1016\/j.josat.2026.210090_bb0070","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00406-024-01880-2","article-title":"Cannabis, cannabinoids and health: A review of evidence on risks and medical benefits","volume":"275","author":"Hoch","year":"2025","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"4","key":"10.1016\/j.josat.2026.210090_bb0075","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jama.2025.19433","article-title":"Therapeutic use of cannabis and cannabinoids: A review","volume":"335","author":"Hsu","year":"2026","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2026.210090_bb0080","series-title":"Critical Appraisal Tools","author":"JBI","year":"2024"},{"key":"10.1016\/j.josat.2026.210090_bb0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2025.8215","article-title":"Cannabis and mental health: A review","author":"Kansagara","year":"2026","journal-title":"JAMA Internal Medicine"},{"issue":"25","key":"10.1016\/j.josat.2026.210090_bb0090","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.2174\/13816128113199990620","article-title":"Acute and long-term effects of cannabis use: A review","volume":"20","author":"Karila","year":"2014","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.josat.2026.210090_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2020.106479","article-title":"What is the prevalence and risk of cannabis use disorders among people who use cannabis? A systematic review and meta-analysis","volume":"109","author":"Leung","year":"2020","journal-title":"Addictive Behaviors"},{"issue":"10","key":"10.1016\/j.josat.2026.210090_bb0100","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1111\/add.15951","article-title":"Age\u2013period\u2013cohort analysis of trends in tobacco smoking, cannabis use, and their co-use in the Australian population","volume":"117","author":"Leung","year":"2022","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.josat.2026.210090_bb0105","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/ntr\/ntz170","article-title":"Cannabis and alcohol co-use in a smoking cessation pharmacotherapy trial for adolescents and emerging adults","volume":"22","author":"McClure","year":"2020","journal-title":"Nicotine and Tobacco Research"},{"issue":"Pt B","key":"10.1016\/j.josat.2026.210090_bb0110","article-title":"Varenicline as a treatment for cannabis use disorder: A placebo-controlled pilot trial","volume":"229","author":"McRae-Clark","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2026.210090_bb0130","doi-asserted-by":"crossref","DOI":"10.4172\/2155-6105.1000222","article-title":"The effect of varenicline administration on cannabis and tobacco use in cannabis and nicotine dependent individuals - A case-series","author":"Newcombe","year":"2015","journal-title":"Journal of Addiction Research & Therapy"},{"issue":"1","key":"10.1016\/j.josat.2026.210090_bb0135","article-title":"Pharmacotherapies for cannabis dependence","volume":"1","author":"Nielsen","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1016\/j.josat.2026.210090_bb0140","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012229","article-title":"A brain on cannabinoids: The role of dopamine release in reward seeking","volume":"2","author":"Oleson","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"10.1016\/j.josat.2026.210090_bb0150","series-title":"Substance use disorders and behavioral addictions: A comprehensive guide","first-page":"1","article-title":"DSM-5 criteria","author":"Raffoul","year":"2025"},{"issue":"2","key":"10.1016\/j.josat.2026.210090_bb0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.edurev.2010.12.001","article-title":"Eta squared and partial eta squared as measures of effect size in educational research","volume":"6","author":"Richardson","year":"2011","journal-title":"Educational Research Review"},{"key":"10.1016\/j.josat.2026.210090_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.lana.2026.101373","article-title":"The prevalence of cannabis use pre-versus post-cannabis legalization in Canada by mental health status: Findings from national repeat cross-sectional surveys","volume":"55","author":"Rundle","year":"2026","journal-title":"Lancet Regional Health \u2013 Americas"},{"issue":"21","key":"10.1016\/j.josat.2026.210090_bb0175","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1523\/JNEUROSCI.0027-07.2007","article-title":"Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuse","volume":"27","author":"Solinas","year":"2007","journal-title":"Journal of Neuroscience"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926002109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926002109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:28:52Z","timestamp":1791653332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926002109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":23,"alternative-id":["S2949875926002109"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.210090","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Varenicline for the management of cannabis use disorder: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.210090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"210090"}}